Survivors of childhood central nervous system cancer show affected self-identity
the ONA take:
According to a new study published in the journal Neuro-Oncology, researchers from the Korlinska Institutet in Sweden have found that patients treated for central nervous system (CNS) cancer during childhood or adolescence can display altered self-perception and self-identify later in adulthood.
For the study, researchers followed 700 adult survivors of childhood CNS cancer who were diagnosed between 1992 and 2001. Researchers compared these patients to a control group from the general population. They studied how the cancer, the treatment, and the aftermath affected the patient's health, function, and psychological identity. Psychological identity includes their self-perception and self-esteem, which researchers assessed using a standardized self-report questionnaire.
Results showed that all components of having CNS cancer affected patients' psychological identity later in adulthood. Researchers found survivors more often had a negative self-perception compared with the control group.
For example, in the context of work and friends, 22% and 30% of survivors had a negative self-perception, respectively, while 8% and 17% of the control group had a negative self-perception, respectively.
Results of self-perception were similar across both groups in the context of family. Findings suggest that more preventative measures are necessary to aid in long-term personality development.
Patients treated for CNS cancer during childhood can display altered self-perception later in adulthood.
The study followed 700 adult survivors diagnosed 1992-2001 with a childhood CNS tumour. The study group covered all adult brain tumour survivors in Sweden at the time of start of study. Patients were compared with a control group selected from the general population.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Radiotherapy is Essential in Treating Brain Tumors But Associated With Significant Adverse Events
- Prostate-specific PET and CT Imaging Improves Detection of Disease and Patient Care
- Lenvatinib Improves OS, PFS in Radioiodine-Refractory Differentiated Thyroid Cancer in All Older Patients
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|